REGENXBIO Inc. (RGNX) stock
RGNXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$7.26+0.02 (+0.28%)
Close on Nov 18, 2026Market cap $479.26MP/E –Yield –
Regenxbio market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Regenxbio's market cap was $458.77M on Nov 11, 2026, against $677.79M a year earlier. Over the last 5 years it ranged from $325.54M to $1.42B, with a median of $677.79M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $458.77M | -37.1% |
| 2025 | Dec 31, 2025 | $728.91M | +90.4% |
| 2024 | Dec 31, 2024 | $382.90M | -51.5% |
| 2023 | Dec 29, 2023 | $789.64M | -19.6% |
| 2022 | Dec 30, 2022 | $981.86M | -29.8% |
| 2021 | Dec 31, 2021 | $1.40B | -17.6% |
| 2020 | Dec 31, 2020 | $1.70B | +12.4% |
| 2019 | Dec 31, 2019 | $1.51B | +0.8% |
| 2018 | Dec 31, 2018 | $1.50B | +44.8% |
| 2017 | Dec 29, 2017 | $1.03B | +110.6% |
| 2016 | Dec 30, 2016 | $491.11M | +12.5% |
| 2015 | Dec 31, 2015 | $436.68M | – |
See a number that looks wrong?